16 Jun 2019 | 7:13 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
535.00
-4.80
(-0.88 %)
14 Jun 2019 | 04:01 PM
Change company
  • Open (Rs)
    538.00
  • Prev. close (Rs.)
    539.80
  • High (Rs.)
    538.00
  • Low (Rs.)
    527.50
  • 52W H (Rs.)
    841.70
  • 52W L (Rs.)
    482.00
  • Volume
    309089
  • MCap (Rs in Cr.)
    9,784.30
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
35.31
Operating Margin (%)
37.94
Gross Profit Margin (%)
34.07
Net Profit Margin (%)
30.76
Total Debt/Equity
0.11
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

28 May 2019 - 13:20:00-Natco Pharma Ltd. on Monday 27 May 2019 has announced Interim dividend of 62...
27 May 2019 - 16:40:00-The company reported standalone net profit of Rs 123...
12 Feb 2019 - 17:11:00-The company reported standalone net profit of Rs 162...
31 Jan 2019 - 14:49:00-Natco Pharma Thursday said it has submitted an abbreviated new drug application (ANDA) with the US h...

Announcements

13-Jun-2019
Natco Pharma - Updates
13-Jun-2019
Natco Pharma - Disclosure Under Regulation 30.Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
07-Jun-2019
Natco Pharma - Investor Presentation
07-Jun-2019
Natco Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation
06-Jun-2019
Natco Pharma - Press Release

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 26.30 -0.42
4,00,000 90.05 145.20 -0.42
4,00,000 90.05 154.37 -0.42
4,00,000 90.05 48.07 -0.41
1,60,000 35.89 68.65 -1.01

Shareholding Pattern

       
Promotors48.71%
Mutual Funds/UTI5.89%
FI/Banks1.25%
Insurance1.25%
FII21.39%
Government0.00%
Others4.31%

Peer Group

Company Intraday Graph
 Procter & Gamble Health Ltd.
3,900.00(-1.60)
3302
 AstraZeneca Pharma India Ltd.
1,890.00(-0.07)
3274
 Dr. Lal Pathlabs Ltd.
1,088.60(0.33)
17140
 Metropolis Healthcare Ltd.
980.50(1.56)
20203

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.0.50-41.50-165.55
NIFTY(S&P CNX)601.25480.051,017.85
BSE SENSEX2,133.541,697.183,489.14
BSE 500726.10333.98892.54

Corporate Details

Key Personal
D Linga Rao
Director & President (Tech. Affairs)
P S R K Prasad
Director & Exe. VP (Corp. Engg. Services)
Rajeev Nannapaneni
Vice Chairman & CEO
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar